Intrahepatic cholestasis in sickle cell disease: A case report

Citations of this article
Mendeley users who have this article in their library.


Intrahepatic cholestasis (SCIC) is an uncommon but potentially fatal complication of sickle cell disease (SCD), with a high death rate, observed mainly in patients with homozygous sickle cell anemia. Herein, we describe a case of severe SCIC treated successfully with aggressive manual exchange transfusion (ET). The patient was admitted with enlarged liver and signs of hepatic failure, such as hyperbilirubinemia and coagulopathy. There was no evidence of viral hepatitis or biliary obstruction. We performed several sessions of ET in order to reduce the percentage of HbS to levels inferior to 30%, which was successfully accomplished. The patient had a complete recovery of hepatic function. This case has shown that ET is an effective treatment of SCIC and should be introduced early on the onset of this severe complication.




Brunetta, D. M., Silva-Pinto, A. C., Favarin De MacEdo, M. D. C., Bassi, S. C., Piccolo Feliciano, J. V., Ribeiro, F. B., … Covas, D. T. (2011). Intrahepatic cholestasis in sickle cell disease: A case report. Anemia, 2011.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free